Nanobiotix SA at UBS Global Healthcare Conference Transcript
Good morning, everyone, and thank you for attending the UBS Global Healthcare Conference. I'm Colin Bristow, one of the biotech analysts at UBS. It's my pleasure to have with us Laurent Levy, CEO of Nanobiotix; and Bart Van Rhijn, CFO of Nanobiotix. Thank you.
(Conference Instructions) So Laurent and Bart, thank you very much for coming today. And I know you have a few points you wanted to relay before we get into questions. So I'll hand it over to you.
Sure. Thank you, Colin. We will be happy to start this chat by telling you a bit more about the company and the technology we are developing. And just maybe starting by the way we look at cancer. We felt that if we bring something really new in cancer treatment, we should not follow others' paths. So we should bring something new for the patients and their family.
So we looked at everything that is out there including chemistry and biology as one of the main stream of the treatment and felt that they bring
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
